NEXGEL, Inc. (NXGL)
NASDAQ: NXGL · Real-Time Price · USD
2.570
+0.160 (6.64%)
At close: Sep 15, 2025, 4:00 PM EDT
2.560
-0.010 (-0.39%)
After-hours: Sep 15, 2025, 4:10 PM EDT
NEXGEL Market Cap
NEXGEL has a market cap or net worth of $20.73 million as of September 15, 2025. Its market cap has increased by 13.04% in one year.
Market Cap
20.73M
Enterprise Value
22.66M
1-Year Change
13.04%
Ranking
Category
Stock Price
$2.57
Market Cap Chart
Since the IPO on December 22, 2021, NEXGEL's market cap has increased from $19.59M to $20.73M, an increase of 5.84%. That is a compound annual growth rate of 1.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 19.44M | -42.01% |
| Dec 31, 2024 | 33.53M | 175.32% |
| Dec 29, 2023 | 12.18M | 74.85% |
| Dec 30, 2022 | 6.97M | -52.05% |
| Dec 31, 2021 | 14.52M | -25.85% |
| Dec 22, 2021 | 19.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |